Investigators from University of Texas MD Anderson Cancer Center Have Reported New Data on Cell Transplants (A Randomized Phase Iii Study of Pretransplant Conditioning for Aml/mds With Fludarabine and Once Daily Iv Busulfan +/- Clofarabine In ...)

MLA

“Investigators from University of Texas MD Anderson Cancer Center Have Reported New Data on Cell Transplants (A Randomized Phase Iii Study of Pretransplant Conditioning for Aml/Mds With Fludarabine and Once Daily Iv Busulfan +/- Clofarabine In ...).” Stem Cell Week, June 2022, p. 503. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.707588759&authtype=sso&custid=ns315887.

APA

Investigators from University of Texas MD Anderson Cancer Center Have Reported New Data on Cell Transplants (A Randomized Phase Iii Study of Pretransplant Conditioning for Aml/mds With Fludarabine and Once Daily Iv Busulfan +/- Clofarabine In ...). (2022, June 20). Stem Cell Week, 503.

Chicago

Stem Cell Week. 2022. “Investigators from University of Texas MD Anderson Cancer Center Have Reported New Data on Cell Transplants (A Randomized Phase Iii Study of Pretransplant Conditioning for Aml/Mds With Fludarabine and Once Daily Iv Busulfan +/- Clofarabine In ...),” June 20. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.707588759&authtype=sso&custid=ns315887.